Webex Link: https://uwhealth.webex.com/uwhealth/j.php?MTID=m398b5099541b81f1b40740bd5e213c1f

Learning Objectives:

  1. Summarize the presentation, diagnosis, and current guideline-recommended treatment options for vulvovaginal candidiasis (VVC)

  2. Describe the safety and efficacy of ibrexafungerp for VVC

  3. Describe the safety and efficacy of oteseconazole for VVC

  4. Evaluate the role of ibrexafungerp and oteseconazole in the treatment of VVC

Session date: 
03/20/2025 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 

Please login or register to take this course.
Presenter(s): 
Michelle Wu, Mara Gosch, and Kelby Drogemuller